Skip to content
-

We are dedicated to providing innovative treatments, collaborations with healthcare stakeholders and advocating for skin conditions as public health priorities

Healthcare professionals and healthcare organizations provide us with valuable, independent and expert knowledge from their experience within the therapeutic focus area of LEO Pharma.

Partnerships that drive progress 

 

At present LEO Pharma provide grants to Global Parents for Eczema Research, International Alliance of Dermatological Patient Organizations/Global Skin and International Federation of Psoriasis Associations/IFPA. Furthermore, we donate drugs to International Health Partners" As we move into rare(r) skin diseases, we will strategically reconsider the current patient group grants and will most likely take a new approach from 2025 meaning, we shouldnt flag a long-standing dedication to these specific organizations. 

 

Image

 

Our partners: 

 

logologo
logologo

 

Our future approach to patient engagement  

 

We are dedicated to evaluating where LEO Pharma can make the biggest impact before we set the direction for our future engagement with patients, and we have taken the first steps in systematically building an inclusive clinical trials infrastructure to make sure we accommodate diverse populations in relevant markets where LEO Pharma operates. 

 

From crisis response to sustainable impact

 

Our commitment to address humanitarian crises around the world remains unchanged. For over a decade, we have partnered closely with International Health Partners to ensure the delivery of our medicines to areas and patients in dire need. From 2013-2023, our response to emergencies has included donations of more than 325,000 units of medical products that have provided essential relief during critical situations through 26 shipments to 29 countries, reaching approximately 380,000 patients.